Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Expleo Solutions Limited ( (IN:EXPLEOSOL) ) is now available.
Expleo Solutions Limited has disclosed that the Principal Commissioner of Income Tax in Chennai has granted the company immunity from a disputed tax demand of about ₹49.6 lakh for assessment year 2012-13 under the Vivad Se Vishwas Scheme, 2024. The order, received on March 24, 2026, confirms full and final settlement of the tax arrears with no payment required from Expleo and, according to the company, will not have a material impact on its financials, operations or other activities.
The dispute stemmed from certain professional expenses that were previously disallowed for non-deduction of tax deducted at source, but the resolution removes this historical liability and closes a long-standing assessment issue. The outcome offers clarity for shareholders on a legacy tax matter and underscores the use of the government’s dispute resolution scheme to clean up contingent tax exposures without affecting ongoing business performance.
More about Expleo Solutions Limited
Expleo Solutions Limited is an India-based provider of software testing, quality assurance and related IT services, serving clients in technology-intensive sectors. Listed on both the BSE and NSE, the company focuses on delivering specialised professional services to domestic and international customers from its base in Chennai.
Average Trading Volume: 1,337
Technical Sentiment Signal: Sell
Current Market Cap: 10.87B INR
See more data about EXPLEOSOL stock on TipRanks’ Stock Analysis page.